A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 65,233 shares of EW stock, worth $4.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
65,233
Previous 66,665 2.15%
Holding current value
$4.27 Million
Previous $6.37 Million 5.42%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $120,717 - $135,051
-1,432 Reduced 2.15%
65,233 $6.03 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $170,904 - $225,139
-2,356 Reduced 3.41%
66,665 $6.37 Million
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $1.22 Million - $1.54 Million
19,750 Added 40.08%
69,021 $5.26 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $25,217 - $33,990
-364 Reduced 0.73%
49,271 $3.41 Million
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $58,533 - $67,823
-719 Reduced 1.43%
49,635 $4.68 Million
Q1 2023

May 16, 2023

BUY
$74.26 - $84.51 $72,403 - $82,397
975 Added 1.97%
50,354 $4.17 Million
Q4 2022

Feb 13, 2023

SELL
$68.3 - $87.44 $142,747 - $182,749
-2,090 Reduced 4.06%
49,379 $3.68 Million
Q3 2022

Nov 16, 2022

BUY
$82.37 - $107.29 $4.24 Million - $5.52 Million
51,469 New
51,469 $4.25 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $0 - $0
0 New
0 $4.25 Million
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $3,460 - $5,130
-40 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $4,078 - $5,133
40 New
40 $5,000
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $4,232 - $5,508
-63 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $2,416 - $3,231
42 Added 200.0%
63 $4,000
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $1,170 - $1,352
21 New
21 $4,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Kayne Anderson Rudnick Investment Management LLC Portfolio

Follow Kayne Anderson Rudnick Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.